MDS is a bone marrow failure disorder
Medical & Scientific Advisory Board (MSAB)
Mario Cazzola, MD – Chairman

Professor of Hematology
University of Pavia School of Medicine
Fondazione IRCCS Policlinico San Matteo
Pavia, Italy

Rafael Bejar, MD

Assistant Professor
University of California, San Diego
Moores Cancer Center
La Jolla, California, U.S.A.


Rena Buckstein, MD

Head Hematology Site Group
Co-Director of MDS Research Program
Odette Cancer Center
Toronto, Ontario, Canada

Theo J.M. de Witte, MD, PhD

Professor of Hematology
Radboud University Medical Center
Radboud Institute of Molecular Life Sciences
Nijmegen, The Netherlands


Erin P. Demakos, RN, CCRN

Administrative Director
Myelodysplastic Disease Center
Icahn School of Medicine at Mount Sinai
New York, New York, U.S.A.

Benjamin Ebert, MD, PhD

Associate Professor of Medicine
Brigham and Women’s Hospital
Harvard Medical School
Boston, Massachusetts, U.S.A


Silvia M. M. Magalhães, MD, PhD

Professor of Clinical Medicine – Hematology
Federal University of Ceará
Hospital Universitário Walter Cantídio
Ceará, Brazil

Yasushi Miyazaki, MD

Chief, Department of Hematology
Nagasaki University Graduate School of Biomedical Sciences
Atomic Bomb Disease Institute
Nagasaki, Japan


Ghulam J. Mufti, DM, FRCP, FRCPath

Head of Department
Professor of Haemato Oncology in Haematological Medicine
King’s College London & King’s College Hospital
London, United Kingdom

Uwe Platzbecker, MD

Professor of Hematology
University Hospital Carl Gustav Carus
Dresden, Germany


Akiko Shimamura, MD, PhD

Director, Bone Marrow Failure & MDS Programs
Boston Children’s Hospital
Associate Professor of Pediatrics
Harvard Medical School
Boston, Massachusetts, U.S.A.

Lewis Silverman, MD

Associate Professor of Medicine, Hematology and Medical Oncology
Assistant Professor of Oncological Sciences
Icahn School of Medicine at Mount Sinai
New York, New York, U.S.A.


Review answers to commonly asked questions or get answers to your questions from an MDS expert